Background and aims New data has emerged regarding higher risk of coronavirus disease
2019 (COVID-19), and its severity and complications in patients with type 2 diabetes mellitus …

Type 1 diabetes is a chronic, immune-mediated disease characterised by the destruction of
insulin-producing cells. Standardised registry data show that type 1 diabetes incidence has …

OBJECTIVE The aim of this study was to investigate the incidence of type 1 diabetes in
children and adolescents during the coronavirus disease 2019 (COVID-19) pandemic in …

The incidence of type 1 diabetes has risen considerably in the past 30 years due to changes
in the environment that have been only partially identified. In this Series paper, we critically …

The epidemic nature of diabetes mellitus in different regions is reviewed. The Middle East
and North Africa region has the highest prevalence of diabetes in adults (10.9%) whereas …

Type 1 diabetes is diagnosed at the end of a prodrome of β-cell autoimmunity. The disease
is most likely triggered at an early age by autoantibodies primarily directed against insulin or …

Type 1 diabetes mellitus (T1DM) results from the destruction of pancreatic β-cells that is
mediated by the immune system. Multiple genetic and environmental factors found in …

Type 1 diabetes is an autoimmune disease caused by the immune-mediated destruction of
pancreatic β cells that results in lifelong absolute insulin deficiency. For nearly a century …

Objective To assess the risk of new-onset type 1 diabetes mellitus (T1D) diagnosis following
COVID-19 diagnosis and the impact of COVID-19 diagnosis on the risk of diabetic …

In general, infectious diseases are more frequent and/or serious in patients with diabetes
mellitus, which potentially increases their morbimortality. The greater frequency of infections …